145 related articles for article (PubMed ID: 20447407)
1. Asymmetric recruitment of cIAPs by TRAF2.
Mace PD; Smits C; Vaux DL; Silke J; Day CL
J Mol Biol; 2010 Jul; 400(1):8-15. PubMed ID: 20447407
[TBL] [Abstract][Full Text] [Related]
2. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
[TBL] [Abstract][Full Text] [Related]
4. The Odd Faces of Oligomers: The Case of TRAF2-C, A Trimeric C-Terminal Domain of TNF Receptor-Associated Factor.
Di Venere A; Nicolai E; Minicozzi V; Caccuri AM; Di Paola L; Mei G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070875
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
[TBL] [Abstract][Full Text] [Related]
6. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.
Vince JE; Pantaki D; Feltham R; Mace PD; Cordier SM; Schmukle AC; Davidson AJ; Callus BA; Wong WW; Gentle IE; Carter H; Lee EF; Walczak H; Day CL; Vaux DL; Silke J
J Biol Chem; 2009 Dec; 284(51):35906-15. PubMed ID: 19815541
[TBL] [Abstract][Full Text] [Related]
7. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for self-association and receptor recognition of human TRAF2.
Park YC; Burkitt V; Villa AR; Tong L; Wu H
Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
[TBL] [Abstract][Full Text] [Related]
9. Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2.
Vischioni B; Giaccone G; Span SW; Kruyt FA; Rodriguez JA
Exp Cell Res; 2004 Aug; 298(2):535-48. PubMed ID: 15265700
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
11. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.
Feltham R; Bettjeman B; Budhidarmo R; Mace PD; Shirley S; Condon SM; Chunduru SK; McKinlay MA; Vaux DL; Silke J; Day CL
J Biol Chem; 2011 May; 286(19):17015-28. PubMed ID: 21393245
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the lack of E2 interaction in the RING domain of TRAF2.
Yin Q; Lamothe B; Darnay BG; Wu H
Biochemistry; 2009 Nov; 48(44):10558-67. PubMed ID: 19810754
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.
Feltham R; Moulin M; Vince JE; Mace PD; Wong WW; Anderton H; Day CL; Vaux DL; Silke J
J Biol Chem; 2010 Jun; 285(23):17525-36. PubMed ID: 20356846
[TBL] [Abstract][Full Text] [Related]
15. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
[TBL] [Abstract][Full Text] [Related]
16. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination.
Dueber EC; Schoeffler AJ; Lingel A; Elliott JM; Fedorova AV; Giannetti AM; Zobel K; Maurer B; Varfolomeev E; Wu P; Wallweber HJ; Hymowitz SG; Deshayes K; Vucic D; Fairbrother WJ
Science; 2011 Oct; 334(6054):376-80. PubMed ID: 22021857
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.
Kim CM; Jeong JH; Son YJ; Choi JH; Kim S; Park HH
FEBS Lett; 2017 Mar; 591(5):810-821. PubMed ID: 28155233
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.
Csomos RA; Brady GF; Duckett CS
J Biol Chem; 2009 Jul; 284(31):20531-9. PubMed ID: 19506082
[TBL] [Abstract][Full Text] [Related]
20. Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2.
Erba F; Di Paola L; Di Venere A; Mastrangelo E; Cossu F; Mei G; Minicozzi V
Biomol Concepts; 2023 Jan; 14(1):. PubMed ID: 37377424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
